Accolade Inc (ACCD) 옵션

This buyout was fraud committed on shareholders, they knew 2 years ago they were going to play every shareholder and pay them only $7 per share, but 1st they had to bring the PPS down from $15 below $4 and they did just that.

2 years ago in October they got a big contract from International Paper with over 60,000 employees.

Cigna had that contract and they lost it to Accolade, on insider trading the stock flew from $6 to $15 in 2 months with news of that big contract and that kind of messed their plans up, so they had to wait it out, so Transcarent can buy them out and then quickly announce delisting.

ACCD: Buyout news.

ACCD under $4

ACCD new 52 week low

That awful Cathie Wood bought more shares

ACCD That awful Cathie Wood bought shares.
Accolade Inc NASDAQ: ACCD

GoSymbol lookup
Health Care : Health Care Providers & Services | Small Cap BlendCompany profile
Accolade, Inc. provides personalized, technology-enabled solutions that help people understand, navigate, and utilize the healthcare system and their workplace benefits. Its customers are primarily employers that deploy Accolade solutions in order to provide employees and their families with a single place to turn for their health, healthcare, and benefits needs. It also offers medical opinion services to commercial customers and virtual primary care and mental health support. Its platform, True Health Engine, combines open, cloud-based intelligent technology with multimodal support from a team of empathetic and knowledgeable Accolade Health Assistants and clinicians, including registered nurses, physician medical directors, pharmacists, behavioral health specialists, women’s health specialists, case management specialists, expert medical opinion providers, and virtual primary care physicians. Its offerings include Accolade Expert MD, Accolade Care, Plus and Connect and Accolade One.

Will this help their stock price?
https://finance.yahoo.com/news/accolade-expands-mental-health-integrated-130000009.html

ACCD down 50% will lose big customer end of year and always has loses on increased revenue, spends a ton on research and dev.

Accolade Sees Q4 Sales $90M-$93M vs $97.71M Est., Raises FY22 Sales Guidance From $303M-$307M To $306M-$309M vs $306.34M Est.

Accolade Inc. is a provider of personalized, technology-enabled solutions that helps people to understand, navigate, and utilize the healthcare system and their workplace benefits. The Company’s customers are primarily employers that deploy Accolade in order to provide employees and their families members a single place to turn for their health, healthcare, and benefits needs. Its platform combines open, cloud-based intelligent technology with multimodal support from a team of empathetic and knowledgeable Accolade Health Assistants and clinicians, including nurses, physician medical directors, and behavioral health specialists. The Company leverages its integrated capabilities, connectivity with providers and the healthcare ecosystem, and longitudinal data to engage across the member population. Its offerings are: Accolade Total Benefits, Accolade Total Care, Accolade Total Health and Benefits, Accolade Boost, the Trusted Supplier Program, and Mental Health Integrated Care solutions.